PTSD – HealthQuill

About Us

Bharti Rana Jayshankar – Founder

She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.

Jay Shankar – Co-founder

He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.

Contact Info

info@healthquill.com

Bionomics Limited, a clinical-stage biotechnology company announced positive outcomes for its experimental drug to treat post-traumatic stress disorder (PTSD).

Bionomics’ PTSD experimental drug yield positive results in trials

HQ Team September 29, 2023: Bionomics Limited, a clinical-stage biotechnology company announced positive outcomes for its experimental drug to treat post-traumatic stress disorder.

by HealthQuill
September 29, 2023
0 Comments

About Us

Contact Info

Follow Us

Bionomics’ PTSD experimental drug yield positive results in trials